Medivir AB (Medivir AB) 3-Year Revenue Growth Rate : -31.10% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medivir AB 3-Year Revenue Growth Rate?

Medivir AB's Revenue per Share for the three months ended in Mar. 2024 was $0.00.

During the past 12 months, Medivir AB's average Revenue per Share Growth Rate was 35.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -31.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -28.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -42.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Medivir AB was 85.90% per year. The lowest was -69.00% per year. And the median was -23.65% per year.

Competitive Comparison of Medivir AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Medivir AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medivir AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medivir AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medivir AB's 3-Year Revenue Growth Rate falls into.

Medivir AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Medivir AB (OTCPK:MVRBY) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Medivir AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medivir AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medivir AB (Medivir AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medivir AB (OTCPK:MVRBY) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

MVIR:Sweden MVR0:Germany MVR0:Germany

Address

Lunastigen 5, PO Box 1086, 2nd floor, Huddinge, SWE, 141 22

Website

https://www.medivir.com

Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there are opportunities to offer significant improvements to patients. Medivir focuses on the development of MIV-818, a prodrug that has been designed to provide a targeted anti-tumor effect in the liver while minimizing any side effects. Birinapant, a SMAC mimetic, has been out-licensed for development in combination with IGM antibodies for the treatment of solid tumors.